|
|
<section data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.jpg" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p><br /></p><section><span></span></section><section data-mpa-powered-by="gulangu"><section><section><section><section><section><section><section data-mpa-powered-by="gulangu"><section><section><section><section><section><section><section><section powered-by="gulangu"><section><section><section><section><section powered-by="gulangu"><section><span>国药集团中国生物负责人日前就新冠灭活疫苗紧急使用和海外Ⅲ期临床研究情况接受媒体采访时透露，国药中国生物研制的两款新冠灭活疫苗已经接种了数十万人次，无一例明显不良反应，无一人感染；其中打完疫苗之后去往海外高风险国家和地区的数万人，截至目前零感染。</span></section></section></section></section></section></section></section></section><section><br /></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><section data-mpa-powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/a4483e74eeae3fd04c507aea8e9ed87b_2.jpg" /></p></section><section><span>（资料图）</span></section><section><span><br /></span></section><p><br /></p><section><span>国药中国生物总法律顾问周颂介绍，国内新冠灭活疫苗获批临床试验的有三支，国药中国生物就占了其中两支，也是目前紧急使用接种量最大、人数最多的。周颂强调，意义更为重大的是，新冠灭活疫苗的紧急使用，面向的都是高风险暴露人群，比如救治新冠病毒感染者的医护人员，以及去往疫情高风险国家的外交人员、外派员工和中资企业“一带一路”建设人员等等。</span><span>这几万人打完疫苗之后，已经到海外几个月时间了，其中在疫情暴发的地区，有留守的员工感染了，他们没有感染。类似这样的平行对照数据在多个国家都有，这证明了疫苗的有效性</span><span>。</span></section><section><span><br /></span></section><p><br /></p><section><span>国药中国生物副总裁张云涛表示，新冠灭活疫苗Ⅰ、Ⅱ期临床研究在国内开展，都产生了中和抗体。“中和抗体检测是个金标准”，在海外的Ⅲ期临床研究中，也会持续观察中和抗体。中和抗体是可比较的，在海外的试验扩大了人种、国家和人群，最主要还是被海外认可，对于以后的应用会更好。</span></section><section><span><br /></span></section><p><br /></p><section><span>张云涛说，以前我们的疫苗想出口是很难的，有一系列的法规和临床限制。现在我们的科技实力强了，Ⅰ、Ⅱ期临床试验数据被海外认可，在海外直接开展Ⅲ期临床研究，是国际合作的典范。未来，中国审批通过，这些国家只要做了临床研究，也都可以合法合规上市。他透露，目前，新冠灭活疫苗在国际上有5亿剂意向订单。</span></section><section><br /></section><section powered-by="gulangu"><section><p><img src="image/20201014/a51a194df1b05516b19653e0bbd8b63e_3.png" /></p></section></section><section><span>科技日报报道截图</span></section><section><br /></section></section></section></section><section powered-by="gulangu"><section><span>来源：科技日报/瞿剑</span></section><p><span><strong><br /></strong></span></p></section></section></section></section></section></section><section><section data-color="#757576"><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section><section><br /></section></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_4.gif" /></p></section><section data-brushtype="text"><span>戳一下，更有料！</span></section></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983345&idx=1&sn=0af866e9af58fb55c9b367b7d0f33dc9&chksm=843f32a6b348bbb031d6f5d8c17e830a74ea2e0b8635e3c1fbf202d50c012a747b5a1b516e49&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>CMEF2020十大必看磁共振产品</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983345&idx=2&sn=5216eb12ab2bc3625e20c6d91a4e292a&chksm=843f32a6b348bbb0a6988dced7aa066b9f142979c0a75722661c7e5ca6c6f02991f4d899eb30&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>大健康领衔，美国未来5大重点研发领域！</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983345&idx=3&sn=0bc56fffa17a2d48d5d58151839a200c&chksm=843f32a6b348bbb08ed5bc4040b7d158b170318d52c7d464d77ed22ef2aea85774679e170db6&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>静脉输液气泡清除系统——ClearLine</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983304&idx=1&sn=d5f8ed83cfe69ca9aa41af49a02ce95d&chksm=843f329fb348bb897c413457ac1ebda31fc2db876496aa4f78229f69901f88c9faefb5fbfb1f&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>走访株洲市二医院：三级医院采购DR更看重哪些方面？</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983304&idx=2&sn=c21313106b2715f627e53b3bff4a58ff&chksm=843f329fb348bb89ce25625f3a3b683e70e45eb9010c3f1531545bc438a834122f6b2b270f02&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>英国“疫苗之光”暂停实验！中国创业板牛股跌停！</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652983304&idx=3&sn=bce4472919431249bd0faf944d9da8d6&chksm=843f329fb348bb892b736d8d77f1c423ca060377be449b316b7678c0cd160cf0f0a63f8c9a9e&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2"><span>别再羡慕马斯克的脑机接口了！中国强大的脑机接口在这里</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652980893&idx=1&sn=8d2b3ca8aacc952e5745810c0d500741&chksm=843f240ab348ad1ca179067fc31e5c356ad48ca214c0cd00f8b903ad967eaea71d16991553a3&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>最新 | 52家中国医疗器械企业大排行</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652980893&idx=2&sn=fe2637f5c64c07e306b6a2501d52b2ae&chksm=843f240ab348ad1cd078b34e4cff1a46f6cd8402c692ff6fac86f64283f95ec3c304bfc3d3bc&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2"><span>2020中国综合医院门急诊量排行榜出炉！</span></a><br /></section><section><br /></section><section><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652980892&idx=1&sn=9d7b04b825f217f80d5d425bccd8d195&chksm=843f240bb348ad1d1c643c8bd2ec70cfdbfd01062e6de4e01e7a2d1a76e34af74b7227aa74d8&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>70秒！GE资助：揭秘极速磁共振扫描技术</span></a><br /></section><section><br /></section><section><span><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652980892&idx=2&sn=5104e2c0897a18ecf42d38960c84dc88&chksm=843f240bb348ad1d5ad5fc0deddadd34e4624e0b1e76bd6f7495d233ce5a4ae7dfd9ab5c873d&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2">后疫情时代，医疗设备的最强防线和数字化发展趋势</a></span></section></section></section></section></section></section></section></section><section><br /></section><section><span>商务合作：4008228766@qixieke.com</span></section><section><br /></section><section><p><img src="image/20201014/aad9f56b0707b5374bbac6273a663447_5.jpg" /></p></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section>
|
|
发表于 2020-10-14 10:50:26